Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation
therapy, such as bicalutamide, leuprolide, and goserelin, may lessen the amount of androgens
made by the body. Vaccine therapy may help the body build an effective immune response to
kill tumor cells. It is not yet known whether androgen ablation therapy is more effective
with or without vaccine therapy in treating patients with prostate cancer.
PURPOSE: This randomized phase II trial is studying androgen ablation therapy to see how well
it works when given together with or without vaccine therapy in treating patients with
prostate cancer.